ABT Income Statement

Abbott Laboratories - Revenue, Expenses & Profit Analysis

Stock Price

$116.35

Market Cap

$202.50B

P/E Ratio

31.3

EPS (TTM)

$3.72

Most Recent Quarter

Period: FY(2025-12-31)

Revenue

Total sales from operations

$44.33B

+5.7% YoY

Cost of Revenue

Direct costs of sales

$19.32B

Gross Profit

Revenue - Cost of Revenue

$25.01B

Margin: 56.7%

Operating Income

Gross Profit - Operating Expenses

$8.05B

Margin: 0.2%

Net Income

Bottom line profit

$6.52B

Margin: 0.1%

Earnings Per Share (Diluted)

Net income per share

$3.72

Profitability Metrics

Gross Margin

56.7%

Operating Margin

0.2%

Net Margin

0.1%

Return on Equity

0.1%

Historical Income Statements

PeriodRevenueGross ProfitOperating IncomeNet IncomeEPS
FY$44.33B$25.01B$8.05B$6.52B$3.72
2024-12-31$41.95B--$13.40B$7.64
FY$41.95B$23.24B$6.83B$13.40B$7.64
2023-12-31$40.11B--$5.72B$3.26
FY$40.11B$22.13B$6.48B$5.72B$3.26

View Complete Financial Analysis

Full income statements, balance sheets, cash flows, and AI-powered insights

Open Full Analysis

Frequently Asked Questions

What is ABT's revenue?

ABT's most recent quarterly revenue was $44.33B, representing a growth of 5.7% year-over-year.

Is ABT profitable?

ABT reported a profit of $6.52B in the most recent quarter. The net profit margin is 0.1%.

What is ABT's operating income?

ABT's operating income was $8.05B in the most recent quarter. The operating margin is 0.2%.

What is ABT's earnings per share (EPS)?

ABT reported diluted earnings per share of $3.72 in the most recent quarter.

What is ABT's gross profit margin?

ABT has a gross profit margin of 56.7%, indicating the profitability of core operations before operating expenses.

Explore Categories